Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 530.07 KB
  1. Search results
  2. Response to chemotherapy is predictiv...

Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma

Jaine K Blayney, Giovanni L Ceresoli, Bruno Castagneto, Mary ER O'Brien, Baktiar Hasan, Richard Sylvester, Robin Rudd, Jeremy Steele, Sara Busacca, Camillo Porta, et al.
(2012) EUROPEAN JOURNAL OF CANCER. 48(16). p.2983-2992
Author
Organization
Keywords
CANCER COOPERATIVE GROUP, prognosis, mesothelioma, Landmark analysis, survival, PEMETREXED PLUS CARBOPLATIN, PROGRESSION-FREE SURVIVAL, PHASE-II TRIALS, LUNG-CANCER, MALIGNANT MESOTHELIOMA, TUMOR RESPONSE, EORTC, VINORELBINE, CISPLATIN

Downloads

  • Download
    (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 530.07 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Blayney, Jaine K, Giovanni L Ceresoli, Bruno Castagneto, Mary ER O’Brien, Baktiar Hasan, Richard Sylvester, Robin Rudd, et al. 2012. “Response to Chemotherapy Is Predictive in Relation to Longer Overall Survival in an Individual Patient Combined-analysis with Pleural Mesothelioma.” European Journal of Cancer 48 (16): 2983–2992.
APA
Blayney, J. K., Ceresoli, G. L., Castagneto, B., O’Brien, M. E., Hasan, B., Sylvester, R., Rudd, R., et al. (2012). Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma. EUROPEAN JOURNAL OF CANCER, 48(16), 2983–2992.
Vancouver
1.
Blayney JK, Ceresoli GL, Castagneto B, O’Brien ME, Hasan B, Sylvester R, et al. Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma. EUROPEAN JOURNAL OF CANCER. 2012;48(16):2983–92.
MLA
Blayney, Jaine K, Giovanni L Ceresoli, Bruno Castagneto, et al. “Response to Chemotherapy Is Predictive in Relation to Longer Overall Survival in an Individual Patient Combined-analysis with Pleural Mesothelioma.” EUROPEAN JOURNAL OF CANCER 48.16 (2012): 2983–2992. Print.
@article{3052342,
  author       = {Blayney, Jaine K and Ceresoli, Giovanni L and Castagneto, Bruno and O'Brien, Mary ER and Hasan, Baktiar and Sylvester, Richard and Rudd, Robin and Steele, Jeremy and Busacca, Sara and Porta, Camillo and Mutti, Luciano and O'Byrne, Kenneth J and Scullin, Paula and Gaafar, Rabab and Baas, Paul and Van Meerbeeck, Jan and Fennell, Dean A},
  issn         = {0959-8049},
  journal      = {EUROPEAN JOURNAL OF CANCER},
  keyword      = {CANCER COOPERATIVE GROUP,prognosis,mesothelioma,Landmark analysis,survival,PEMETREXED PLUS CARBOPLATIN,PROGRESSION-FREE SURVIVAL,PHASE-II TRIALS,LUNG-CANCER,MALIGNANT MESOTHELIOMA,TUMOR RESPONSE,EORTC,VINORELBINE,CISPLATIN},
  language     = {eng},
  number       = {16},
  pages        = {2983--2992},
  title        = {Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma},
  url          = {http://dx.doi.org/10.1016/j.ejca.2012.05.018},
  volume       = {48},
  year         = {2012},
}
Altmetric
View in Altmetric
Web of Science
Times cited: